Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer
In this retrospective analysis, ribociclib + NSAI + OFS demonstrated advantages across all effectiveness endpoints, including OS, in premenopausal women with HR+, HER2- early BC, without increasing overall treatment discontinuation rates compared to tamoxifen ± OFS.
Authors
- Stephanie Sussmann
- Michael Untch (ORCID: https://orcid.org/0000-0002-1233-1267)
- Julia Kreuzeder
- D Langanke
- Andreas D. Hartkopf (ORCID: https://orcid.org/0000-0003-1227-1118)
- H. Wohlgemuth
- Diana Lüftner (ORCID: https://orcid.org/0000-0003-2511-9115)
- Almuth Marx
- Marc Thill (ORCID: https://orcid.org/0000-0002-8800-8044)
- Achim Wöckel (ORCID: https://orcid.org/0000-0002-6767-9666)
- Marcus Schmidt (ORCID: https://orcid.org/0000-0003-1365-2414)
- Christian Roos
- Maggie Banys‐Paluchowski
- Andreas Schneeweiß (ORCID: https://orcid.org/0000-0002-2429-4512)
- Manuel Hörner (ORCID: https://orcid.org/0000-0001-6934-992X)
- Peter A. Fasching (ORCID: https://orcid.org/0000-0003-1709-1079)
- Volkmar Müller (ORCID: https://orcid.org/0000-0002-6386-0900)
- Wolfgang Janni
- Lukas Höllrich
- Julia Meinzinger
- Hanna Regus-Leidig
Institutions
- Universität Hamburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Johannes Gutenberg University Mainz (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Novartis (Germany) (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- St. Elisabeth-Krankenhaus Leipzig (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Schleswig-Holstein (DE)
- Universitätsklinikum Würzburg (DE)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Agaplesion Markus Hospital (DE)
- Comprehensive Cancer Center Erlangen (DE)
- IGES Institut (DE)
- Immanuel Krankenhaus (DE)
- University Hospital Ulm (DE)
- Helios Hospital Berlin-Buch (DE)
- University of Tübingen (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Geburtshilfe und Frauenheilkunde
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1055/a-2561-6640
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novartis Pharma